COMPANY PROFILE

       Henan Lihua Pharmaceutical Co., Ltd. was established in 1994, located at Middle of Huanghe Street, Anyang High-tech Industry Development Zone, Henan, China, is the wholly-owned subsidiary of Shanghai Desano Pharmaceuticals Co., Ltd. The total area is 220,000m². Henan Lihua is a National High-tech Enterprise, Custom certificated enterprise and Henan province SRDI enterprise integrating R&D, production and sales of steroids active pharmaceutical ingredients (APIs) and intermediates. And Henan Lihua has more than 600 employees.  

      The product portfolio comprises Prednisolone, Prednisone, Cortisone, Betamethasone and their derivatives, 6 series of more than 60 varieties. These products also meet the following pharmacopeia specifications: Ph. Eur., USP, JP, IP and ChP. Products are presently sold to almost 100 countries in Europe, North and South America, Asia and Africa. Henan Lihua has completed 17 product approvals for domestic API registration and obtained 20 CEP certificates issued by EDQM. Henan Lihua successfully passed site inspection of US FDA with 0 483 and obtained CEP of Clobetasol propionate issued by EDQM without observations. Pfizer, Actylis, Sanofi and other international famous pharmaceutical companies are our long-term and stable important customers.

     Attach great importance to product R&D, we have carried out 23 R&D projects, obtained 24 scientific and technological achievements through independent R&D, and converted more than 8 scientific and technological achievements on average every year. The company has scientific research platforms such as Henan Provincial Enterprise Technology Center, Henan Province Glucocorticoid Engineering Technology Research Center and Provincial and Municipal Steroids Engineering Research Center, and has authorized 35 patents for invention and 8 utility model patents. While strengthening the commercialization of our own research and development results, the company has established close industry-university-research cooperation with the Institute of Microbiology of the Chinese Academy of Sciences, Anyang Normal University and Anyang Institute of Technology, making full use of the advantages of university research institutes and their own technology, information, market, etc., to inject fresh blood for the company's research and development and technological achievements transformation.

      The annual sales revenue of the company is RMB 600 million, the annual export revenue is more than RMB 50 million, and the annual tax is more than RMB 40 million, which has made positive contributions to the economic development of Anyang City, and has become an important new force in the steroid industry at home and abroad.

      The company undertakes the corporate mission of "To be dedicated to corticosteroid substance research and application, meet with customers' demands with exceptional product and service, and constantly enhance human living quality.", always adhering to the core values of "Customer First, Technology-based, Honesty & Pragmatic, Harmony & Win-win", comprehensively strengthening the construction of safety, environmental protection and EHS management system, and promoting the harmonious and sustainable development of enterprises.

      Looking forward to the future, Henan Lihua Pharmaceutical Co., Ltd. is heading for the enterprise vision goal of "To be the leader of steroid hormone industry in the world", striving hard and forging ahead.